Effect of fusaric acid in Parkinson's disease

Medicina (B Aires). 1973 Jan-Feb;33(1):51-8.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Capsules
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / administration & dosage
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / therapeutic use*
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Male
  • Parkinson Disease / drug therapy*
  • Picolinic Acids / administration & dosage
  • Picolinic Acids / adverse effects
  • Picolinic Acids / therapeutic use*
  • Placebos

Substances

  • Antiparkinson Agents
  • Capsules
  • Picolinic Acids
  • Placebos
  • Dihydroxyphenylalanine